MedTrace Logo

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

NCT01550783 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1335

Last updated 2020-07-31

No results posted yet for this study

Summary

This randomized clinical trial studies home-based HPV or clinic-based Pap screening for cervical cancer. It is not yet known whether home-based screening is more effective, cost-effective, and/or acceptable than clinic-based screening for cervical cancer.

Conditions

  • Atypical Squamous Cell of Undetermined Significance
  • Cervical Carcinoma
  • Cervical Intraepithelial Neoplasia Grade 2/3
  • Health Status Unknown
  • Human Papillomavirus Infection
  • Low Grade Cervical Squamous Intraepithelial Neoplasia
  • Stage 0 Cervical Cancer

Interventions

OTHER

Cervical Papanicolaou Test

Undergo standard of care Pap test screening

OTHER

Cytology Specimen Collection Procedure

Undergo home-based HPV screening

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Screening Method

Undergo standard of care Pap test screening

PROCEDURE

Screening Method

Undergo home-based HPV screening

Sponsors & Collaborators

Principal Investigators

  • Nancy Kiviat · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2017-11-16
Completion
2017-11-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01550783 on ClinicalTrials.gov